|
ZFP30 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.467600E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.299700E-03 |
| Normal-vs-Stage2 |
7.145800E-01 |
| Normal-vs-Stage3 |
1.360640E-01 |
| Normal-vs-Stage4 |
4.129700E-02 |
| Stage1-vs-Stage2 |
2.468400E-01 |
| Stage1-vs-Stage3 |
4.02030000000719E-05 |
| Stage1-vs-Stage4 |
4.60590000028738E-07 |
| Stage2-vs-Stage3 |
2.036600E-01 |
| Stage2-vs-Stage4 |
1.122960E-01 |
| Stage3-vs-Stage4 |
6.257200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.626200E-01 |
| Normal-vs-AfricanAmerican |
8.700600E-01 |
| Normal-vs-Asian |
1.727420E-01 |
| Caucasian-vs-AfricanAmerican |
5.321600E-01 |
| Caucasian-vs-Asian |
4.346000E-01 |
| AfricanAmerican-vs-Asian |
2.463000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.601200E-01 |
| Normal-vs-Female |
1.296970E-01 |
| Male-vs-Female |
1.095600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.300200E-01 |
| Normal-vs-Age(41-60Yrs) |
1.159950E-01 |
| Normal-vs-Age(61-80Yrs) |
9.534800E-01 |
| Normal-vs-Age(81-100Yrs) |
3.974200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.712000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.133200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.922000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.032300E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.024000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.863200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.041730E-03 |
| Normal-vs-Grade 2 |
2.724700E-03 |
| Normal-vs-Grade 3 |
4.909200E-01 |
| Normal-vs-Grade 4 |
2.29189999999546E-05 |
| Grade 1-vs-Grade 2 |
8.688400E-02 |
| Grade 1-vs-Grade 3 |
1.061460E-03 |
| Grade 1-vs-Grade 4 |
1.10660000052221E-08 |
| Grade 2-vs-Grade 3 |
2.33129999999138E-05 |
| Grade 2-vs-Grade 4 |
2.28084218178992E-12 |
| Grade 3-vs-Grade 4 |
2.45019999999263E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.361330E-04 |
| Normal-vs-ccB subtype |
1.591600E-01 |
| ccA subtype-vs-ccB subtype |
4.69109999734485E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.950800E-01 |
| Normal-vs-N1 |
8.086300E-02 |
| N0-vs-N1 |
1.574980E-01 |
|
|
